Improving Human Papillomavirus (HPV) Vaccination in the Postpartum Setting

Journal of Community Health

Volumn 42, Issue 1, 2017, Pages 66-71

  Soon, Reni ^a   Sung, Stephen ^a   Cruz, May Rose Dela ^b   Chen, John J ^a   Hiraoka, Mark ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b Papa Ola Lokahi   (United States)

Author keywords

Electronic medical record; Human papillomavirus; Immunizations; Vaccinations

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ELECTRONIC HEALTH RECORD; EPIDEMIOLOGY; FEMALE; HUMAN; ORGANIZATION AND MANAGEMENT; POSTNATAL CARE; PROCEDURES; REMINDER SYSTEM; STATISTICS AND NUMERICAL DATA; TOTAL QUALITY MANAGEMENT; YOUNG ADULT;

ADOLESCENT; ADULT; CONTROLLED BEFORE-AFTER STUDIES; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; PAPILLOMAVIRUS VACCINES; POSTNATAL CARE; QUALITY IMPROVEMENT; REMINDER SYSTEMS; YOUNG ADULT;

EID: 84979993796     PISSN: 00945145     EISSN: 15733610     Source Type: Journal    
DOI: 10.1007/s10900-016-0230-6     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. (2012). Human papillomavirus-associated cancers—United States, 2004–2008. Morbidity and Mortality Weekly Report, 61, 258–261.
2. Singh, G., Miller, B., Hankey, B., & Edwards, B. (2004). Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975–2000. Cancer, 101, 1051–1057.
3. Kahn, J., Lan, D., & Kahn, R. (2007). Sociodemographic factors associated with high-risk human papillomavirus infection. Obstetrics and Gynecology, 110, 87–95.
4. Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R. (2007). Quadrivalant human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports, 56(RR02), 1–24.
5. Kjaer, S. K., Sigurdsson, K., Iversen, O. E., et al. (2009). A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prevention Research, 2, 868–878.
6. Munoz, N., Kjaer, S. K., Sigurdsson, K., et al. (2010). Impact of human papillomavirus (types 6/11/16/18) vaccine on all HPV-associated genital diseases in young women. Journal of the National Cancer Institute, 102, 325–339.
7. Markowitz, L. E., Liu, G., Hariri, S., Steinau, M., Dunne, E. F., & Unger, E. R. (2016). Prevalence of HPV after introduction of the vaccination program in the United States. Pediatrics, 137, 1–9.
8. Slade, B. A., Leidel, L., Vellozzi, C., et al. (2009). Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. Journal of the American Medical Association, 302, 750–757.
9. Centers for Disease Control and Prevention. (2011). Recommendations on the use of quadrivalent human papillomavirus vaccine in males—Advisory Committee on Immunization Practices (ACIP), 2011. Morbidity and Mortality Weekly Report, 60, 1705–1708.
10. American Medical Association. H-440.872 HPV vaccine and cervical cancer prevention worldwide. https://www.ama-assn.org/ssl3/ecomm/PolicyFinderForm.pl?site=www.ama-assn.org&uri=/resources/html/PolicyFinder/policyfiles/HnE/H-440.872.HTM. Accessed May 27, 2016.
11. American Academy of Pediatrics. (2012). Policy statement: HPV vaccine recommendations. Pediatrics, 129, 602–605.
12. American College of Obstetricians and Gynecologists. (2015). Human papillomavirus vaccination. Committee Opinion No.641. Obstetrics and Gynecology, 126, 338–343.
13. Reagan-Steiner, S., Yankey, D., Jeyarajah, J., et al. (2015). National, regional, state and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2014. Morbidity and Mortality Weekly Report, 64, 784–792.
14. Williams, W. W., Lu, P., O’Halloran, A., et al. (2016). Surveillance of vaccination coverage among adult populations—United States, 2014. MMWR Surveillance Summaries, 65(1), 1–36.
15. HealthyPeople.gov. 2020 Topics and Objectives. Immunization and Infectious Diseases. Retrieved from https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-andinfectious-diseases/objectives
16. Soon, R., Dela Cruz, M. R., Tsark, J. U., Chen, J. J., & Braun, K. L. (2015). A survey of physicians’ attitudes and practices about the human papillomavirus (HPV) vaccine in Hawai'i. Hawai'i Journal of Medicine and Public Health, 74, 234–241.
17. Tom, A., Robinett, H., Buenconsejo-Lum, L., et al. (2016). Promoting and providing HPV vaccination in Hawaii: barriers faced by health providers. (published online ahead of print April 2 2016). Journal of Community Health. doi 10.1007/s10900-016-0191-9.
18. Wright, J. D., Govindappagari, S., Pawar, N., et al. (2012). Acceptance and compliance with postpartum human papillomavirus vaccination. Obstetrics and Gynecology, 120, 771–782.
19. Berenson, A. B., Male, E., Lee, T. G., et al. (2014). Assessing the need for and acceptability of a free-of-charge postpartum HPV vaccination program. American Journal of Obstetrics and Gynecology, 210, 213e1–217e1.
20. Donken, R., Knol, M. J., Bogaards, J. A., van der Klis, F. R. M., Meijer, C. J. L. M., & de Melker, H. E. (2015). Inconclusive evidence for non-inferior immunogenicity of two- compared with three-dose HPV immunization schedules in preadolescent girls: a systematic review and meta-analysis. Journal of Infection, 71, 61–73.
21. American College of Obstetricians and Gynecologists. (2013). Integrating immunizations into practice. Committee Opinion No.641. Obstetrics and Gynecology, 121, 897–903.
22. Trick, W., Linn, E., Jones, Z., Caquelin, C., Kee, R., & Morita, J. (2010). Using computer decision support to increase maternal postpartum tetanus, diphtheria, and acellular pertussis vaccination. Obstetrics and Gynecology, 116, 51–57.
23. Ruffin, M. T., Plegue, M. A., Rockwell, P. G., Young, A. P., Patel, D. A., & Yeazel, M. W. (2015). Impact of an electronic health record (EHR) reminder on human papillomavirus (HPV) vaccine initiation and timely completion. The Journal of the American Board of Family Medicine, 28, 324–333.
24. Dela Cruz, M.R., Tsark, J.U., Chen, J.J., Albright, C.L., & Braun, K.L. (2016). Human papillomavirus (HPV) vaccination motivators, barriers, and brochure preferences among parents in multicultural Hawaii: a qualitative study. (published online ahead of print March 7 2016). Journal of Cancer Education. doi 10.1007/s13187-016-1009-2.
25. Cates, J. R., Shafer, A., Carpentier, F. D., et al. (2010). How parents hear about human papillomavirus vaccine: implications for uptake. Journal of Adolescent Health, 47, 305–308.
26. Brewer, N. T., Gottlieb, S. L., Reiter, P. L., et al. (2011). Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sexually Transmitted Diseases, 38, 197–204.
27. Gargano, L. M., Herbert, N. L., Painter, J. E., et al. (2013). Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines. Human Vaccines and Immunotherapeutics, 9, 2627–2633.
28. Smith, P. J., Stokley, S., Bednarczyk, R. A., Orenstein, W. A., & Omer, S. B. (2016). HPV vaccination coverage of teen girls: the influence of health care providers. Vaccine, 34, 1604–16010.
29. Berenson, A.B., Rahman, M., Hirth, J.M., Rupp, R.E., & Sarpong, K.O. (2016). A human papillomavirus vaccination program for low-income postpartum women. (published online ahead of print February 17, 2016). American Journal of Obstetrics and Gynecology. doi:10.1016/j.ajog.2016.02.032.
30. Centers for Disease Control and Prevention. (2013). Human papillomavirus vaccination coverage among adolescent girls, 2007–2012, and postlicensure vaccine safety monitoring, 2006–2013 - United States. Morbidity and Mortality Weekly Report, 2, 591–595.